Clinical Trials List
Protocol NumberALN-TTR02-011
Completed
2019-11-01 - 2025-05-26
Phase III
Terminated1
ICD-10I42.3
Endomyocardial (eosinophilic) disease
ICD-9425.0
Endomyocardial fibrosis
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Shih-Hsien Sung Division of Cardiovascular Diseases
- 王維庭 Division of Cardiovascular Diseases
- 黃偉銘 Division of Cardiovascular Diseases
- Kon-Ping Lin Division of Neurology
- 廖若男 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
5 participants
-
Global
300 participants
